IP Library Granted Patent US 8,246,529
Granted Patent B2
US 8,246,529 · App. 12/892,980 · Granted Aug 21, 2012

Magnetic core for medical procedures

Assignee: Neuronetics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,246,529
App. No.
12/892,980
Granted
Aug 21, 2012
Kind
B2
Abstract

The inventive technique include a system, method and device for treating a patient. The inventive system includes a magnetic field generating device created using a powdered ferromagnetic. The system further includes a circuit in electrical communication with the magnetic core, and a power source in electrical communication with the circuit. The ferromagnetic powder core may be manufactured by at least one of the following: machining, pressing, molding, gluing, and extruding. Also, the ferromagnetic powder core may have a distributed gap structure, where the gap structure operates to focus the magnetic field between pole faces of the magnetic device.

Claims (35)

1. A method of treating a patient, comprising:

creating a magnetic field using a magnetic device having a distributed gap core structure that is adapted for use in connection with transcutaneous magnetic stimulation, wherein the distributed gap core structure comprises a matrix of non-conductive gaps;

applying the magnetic field to the patient; and

treating the patient as a function of the magnetic field.

2. The method of claim 1 , further comprising creating the distributed gap core structure by at least one of the following: machining, pressing, molding, gluing, and extruding.

3. The method of claim 1 , further comprising creating the distributed gap core structure by at least one of the following processes: gluing and attaching individual core structures.

4. The method of claim 1 , further comprising determining motor threshold.

5. The method of claim 4 , further comprising determining a stimulation point as a function of the determined motor threshold.

6. The method of claim 1 , further comprising positioning the patient with respect to the magnetic device.

7. The method of claim 1 , further comprising positioning the magnetic device with respect to the patient.

8. The method of claim 1 , further comprising providing a pulse train of stimulation signals.

9. The method of claim 1 , wherein the distributed gap core structure comprises a powder of ferromagnetic particles coated with an insulative substance.

10. The method of claim 9 , wherein the ferromagnetic particles comprises at least one of the following: a ferromagnetic electrically conductive material, iron, copper, brass and aluminum.

11. The method of claim 1 , further comprising securing the patient with respect to the magnetic device.

12. The method of claim 1 , further comprising treating the patient via diagnosis.

13. The method of claim 1 , further comprising placing the magnetic device in proximity to the patient's head and treating depression.

14. The method of claim 1 , further comprising stimulating a portion of the patient's brain and treating depression.

15. The method of claim 1 , wherein the magnetic device provides the transcutaneous magnetic stimulation.

16. The method of claim 15 , wherein the magnetic device comprises a magnetic core that saturates at 0.5 Tesla or greater.

17. The method of claim 15 , wherein the magnetic device comprises a magnetic core with a non-toroidal geometry.

18. The method of claim 1 , further comprising placing the magnetic device proximate to a cutaneous surface.

19. The method of claim 18 , further comprising stimulating at least one of the following relatively proximate to the cutaneous surface: tissue, nerves and muscle.

20. The method of claim 19 , wherein the tissue is brain tissue.

21. The method of claim 1 , further comprising locating a conductor on a treatment area relative to a first location.

22. The method of claim 21 , further comprising reducing stimulation of a cutaneous-proximate area on the patient.

23. The method of claim 22 , wherein the reducing comprises modifying an electric field created by the transcutaneous magnetic stimulation.

24. The method of claim 23 , wherein the modification of the electric field occurs through modification of a magnetic flux created by the transcutaneous magnetic stimulation.

25. The method of claim 24 , wherein the reducing comprises modifying the magnetic field created by the transcutaneous magnetic stimulation.

26. The method of claim 1 , wherein the core has a non-linear shape.

27. The method of claim 1 , further comprising treating the patients' peripheral nervous system.

28. The method of claim 1 , further comprising treating incontinence.

29. The method of claim 1 , further comprising treating the patient for weight control.

30. The method of claim 1 , further comprising rehabilitating the patient's muscle.

31. The method of claim 1 , further comprising applying the magnetic field in cycles intermittently.

32. The method of claim 1 , further comprising maintaining a temperature of the magnetic device at or below 41.5 degrees Celsius.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Aug 7, 2024
From: SLR INVESTMENT CORP.
To: NEURONETICS, INC.
Reel/Frame 068479/0343 →
SECURITY INTEREST Recorded Jul 26, 2024
From: NEURONETICS, INC.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 068174/0177 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Mar 4, 2020
From: NEURONETICS, INC.
To: SOLAR CAPITAL LTD.
Reel/Frame 052091/0248 →
Continuity (2)
Division 11191106 · Jul 27, 2005
Related Publication 20110015464A1 · Jan 20, 2011